
Company Profile:
At Verastem Oncology, we address urgent needs of patients living with cancers driven by RAS/MAPK pathway mutations, a key driver of tumor growth and treatment resistance. FDA approval of AVMAPKI FAKZYNJA CO-PACK delivered the first therapy for women living with recurrent KRAS-mutated low-grade serous ovarian cancer, a rare cancer with significant unmet need. We’ve launched this novel/novel combination therapy in the U.S. and are exploring pathways for Europe and Japan. We continue to advance our pipeline of drugs to help block cancer cell survival, inhibit tumor growth, and overcome treatment resistance. This is an exciting opportunity to shape the future of cancer care and make a meaningful impact in the lives of patients.
Summary:
The Oncology Account Manager, Gulf Coast (GA, AL, MS), will be responsible for preparing and executing our launch of Avutometinib and Defactinib in LGSOC. This role will report to the Regional Business Director and innately build exceptional customer relationships, perform with strategic agility, and display the importance of collaboration with all functions of the company that impact sales. The right Oncology Account Manager will complement a motivating environment by ensuring clarity of purpose and aligning the company’s wider vision and strategic goals. This individual will use their highly developed clinical and business acumen along with their knowledge of the industry and marketplace to formulate strategies that identify benefits for customers. They will analyze and interpret data and drive sales performance. An exceptional and consistent record of strong sales and performance is critical for this role. The selected candidate will have the responsibility of delivering sales results, be the face of Verastem in front of customers and utilize resources to ensure all goals are exceeded annually.
The base salary range (180K-215K) provided reflects our current estimate of what we anticipate paying for this position. Your actual base salary will be based on several factors, including job-related skills, experience, internal equity, relevant education or training, location, and market dynamics. In addition, you will be eligible for an annual bonus, equity compensation, and a competitive benefits package.

Verastem Oncology (Nasdaq: VSTM) (Verastem, Inc.) is a biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with RAS/MAPK pathway-driven cancers. Our pipeline is focused on novel small molecule drugs that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, including RAF/MEK inhibition, FAK inhibition and KRAS G12D inhibition.
Pursuing unexplored pathways demands that we’re purposeful in everything we do. And it’s an endeavor that’s only possible with an experienced team of employees and partners dedicated to a singular purpose: changing and improving the way cancer is treated by delivering novel therapies that address areas of high unmet need in RAS/MAPK pathway-driven cancers. At Verastem Oncology, it takes our diversity of backgrounds, expertise, perspectives, and skills to find the answers that patients need, but don’t have—yet. To join our team or for more information, please visit www.verastem.com.
X/Twitter: @VerastemOncolog